Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 May 2022
Robert Frater
The research efforts in the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, UFS, have come a long way since the establishment of a homograft bank, animal research, and laboratory-based research on cardioplegia by Prof Hannes Meyer in the 1980s

Several world-class scientists and academics in the field of cardiovascular research will converge at the University of the Free State (UFS) on Thursday (5 May 2022) for a one-day hybrid conference to explore and celebrate the massive strides made in this critical field at the UFS Robert W M Frater Cardiovascular Research Centre.

The research efforts in the Department of Cardiothoracic Surgery in the Faculty of Health Sciences, UFS, have come a long way since the establishment of a homograft bank, animal research, and laboratory-based research on cardioplegia by Prof Hannes Meyer in the 1980s. Renewed interest in 2004 under the leadership of Prof Francis E Smit culminated in the establishment of the Robert W M Frater Cardiovascular Research Centre (the Frater Centre) in 2015. This was made possible through donor funding, especially by Dr Robert W M Frater MD PhD (honoris causa, UFS), a South Africa-born New York-based cardiothoracic surgeon, researcher and innovator as infrastructure and project support by the UFS.

The vision of the Frater Centre is to be a leading cardiovascular research institution in South Africa and sub-Saharan Africa. It provides an interdisciplinary training and research platform for scientists and clinicians from different backgrounds to develop as researchers and collaborators in cardiovascular and thoracic surgery and related domains. Activities are focused on the development of African solutions for African problems.

Three main divisions
The Frater Celebration day will highlight the achievements made thus far in a hybrid format in four sessions, which can be attended on a virtual platform or in person. The centre’s local and international collaborators will participate in the programme, and Dr Ronnie van der Merwe, the Group CEO of Mediclinic International, is the guest of honour.

The Frater Centre consists of three main divisions, all of which will form part of the focus of the conference programme in various forms during the day:

1) The Clinical Research Division addresses cardiovascular disease on a broad front, ranging from population and prevalence studies, healthcare solutions and clinical outcomes studies in a specific South African and African context.

2) The Research, Development and Commercialisation division is divided into Tissue Engineering and Cell Biology, Tissue Banking and Large Animal studies, and bioengineering to develop African solutions and technology within these domains.

3) The Simulation Programme provides an integrated interdisciplinary platform for the education and training of individuals and teams in cardiovascular, thoracic, anaesthetic, perfusion technology and related nursing fields in a state-of-the-art simulation unit. The research centre is developing a unique and leading programme and systems in this field. This endeavour is also developing IT models for training, evaluation and research.

The Frater Centre and 4IR
The Centre is firmly established in the fourth industrial revolution. It is new technology-driven, creating new IT platforms and boasts extensive interdisciplinary projects at the biomedical sector's local, national, and international levels.

It is essential to note that the extensive and successful collaboration within the Frater Centre not only exists on institutional level but also nationally and internationally. These collaborators assist, mentor, direct and contribute to the research activities.

Click: Link to the event
Event programme



News Archive

Rare tumour removed in groundbreaking surgery
2011-08-06

 

Mr Carel Botes and Prof. Francis Smit with a model of the human heart
Photo: Earl Coetzee

A team of surgeons, headed by Prof Francis Smit, Head of our Department of Cardiothoracic Surgery at our Faculty of Health Sciences, performed open heart surgery on a male patient with a malignant tumour.

What makes this operation unique, is that the suspicious mass that was identified in the heart was a rapidly growing and a highly invasive cardiac tumour, which has only been seen in a small number of patients worldwide.

Without the necessary surgery or heart transplant, the prognosis of the patient would have been zero.

The patient, Mr Carl Botes, a 51-year-old farmer from Hoopstad, opted for the tumour to be removed rather than having a heart transplant.  Although both options would involve major risks and challenges, the transplant was the least feasible due to logistics, the waiting list for recipients and the lack of donors.

In the, highly complex, 10-hour operation, performed in the Universitas Academic Hospital in Bloemfontein, the entire right heart chamber had to be removed and the heart reconstructed.

After prolonged hospitalisation of five weeks, Mr Botes was discharged.

Currently he is fully functional and continuing with his active lifestyle.  After three months, all investigations and scans indicate that he is doing very well and has no complaints of fatigue, shortness of breath and palpitations – symptoms which occurred before the removal of the tumour.

For further information contact:
Prof Francis Smit
051-4053861
smitfe@ufs.ac.za
 

Media Release
6 August 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept